Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Abvc Biopharma (ABVC) over the last 15 years, with Q3 2025 value amounting to -$0.05.

  • Abvc Biopharma's EPS (Basic) fell 6666.67% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.29, marking a year-over-year decrease of 14166.67%. This contributed to the annual value of -$0.42 for FY2024, which is 7666.67% up from last year.
  • Abvc Biopharma's EPS (Basic) amounted to -$0.05 in Q3 2025, which was down 6666.67% from -$0.13 recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's EPS (Basic) ranged from a high of $0.28 in Q4 2023 and a low of -$1.54 during Q4 2022
  • For the 5-year period, Abvc Biopharma's EPS (Basic) averaged around -$0.34, with its median value being -$0.13 (2025).
  • In the last 5 years, Abvc Biopharma's EPS (Basic) plummeted by 152857.14% in 2022 and then soared by 11822.82% in 2023.
  • Quarter analysis of 5 years shows Abvc Biopharma's EPS (Basic) stood at -$0.32 in 2021, then crashed by 385.16% to -$1.54 in 2022, then soared by 118.23% to $0.28 in 2023, then crashed by 117.86% to -$0.05 in 2024, then dropped by 0.0% to -$0.05 in 2025.
  • Its last three reported values are -$0.05 in Q3 2025, -$0.13 for Q2 2025, and -$0.06 during Q1 2025.